The 2014 Biocity Annual Lecture showcased Professor Dame Kay Davies, a pioneer in Duchenne Muscular Dystrophy research and Dr Lee’s Professor of Anatomy in the Department of Physiology. Her research interests lie in the molecular analysis of human genetic disease, particularly the genetic basis of neuromuscular and neurological disorders. She first became interested in muscular dystrophy more than 20 years ago and many of her research group are dedicated to finding effective treatments for Duchenne Muscular Dystrophy and spinal muscular atrophy.

In addition, Professor Davies is the director of the MRC Functional Genetics Unit which she set up in 1999, governor of the Wellcome Trust and a director of the Oxford Centre for Gene Function, which she co-founded with Professor Ashcroft and Donnelly to encourage multidisciplinary collaborations between genetics, physiology and bioinformatics.

Led by BioCity Nottingham’s director Toby Reid, the discussion explored what it means to be a successful researcher and the evolution of challenges researchers are faced with. Linked with her extensive scientific research experience Professor Davies has a strong belief in the collaboration between sectors to breach the gap between discovery and taking a product to market, to further the advancement and innovation within the healthcare and life sciences industries.

This support of innovative discoveries and encouraging mutually beneficial collaborations is at the core of BioCity’s business ethos, and Professor Davies’s ongoing research and discoveries, is living proof of the success this can create.

This evening was also a chance to celebrate and showcase BioCity based companies from all sites: BioCity Nottingham, BioCity Scotland, BioHub Alderley Park and following MediCity Nottingham’s success, the development of MediCity Scotland.